
ABOUT COMPREHENSIVE CELL SOLUTIONS, A BUSINESS UNIT OF NYBC ENTERPRISES
Founded in 2003 as a business unit of New York Blood Center Enterprises, CCS offers its deep expertise in the development and manufacture of cell and gene therapies, using its GMP and GTP facilities. CCS provides a true vein-to-vein solution, spanning fresh cellular collections and cord blood-derived stem cells as source material, to cell isolation, manipulation and cryopreservation capabilities for preclinical to commercial stage products. CCS boasts a client roster comprised of the world’s leading pharmaceutical companies, innovative biotechnology organizations, and academic medical centers. CCS maintains its headquarters in New York City, where it offers its full service CDMO capabilities from cellular collections and clinical apheresis through manufacturing and cryopreservation. Additional collection suites, apheresis services, and development and manufacturing operations are offered at sites in Providence, RI, Kansas City, MO, St. Paul, MN, Houston, TX and Louisville, KY.
FEATURED SERVICES
CONTACT INFORMATION
Comprehensive Cell Solutions, A Business Unit of NYBC Enterprises
210 E. 67th Street
New York, NY 10065
UNITED STATES
Phone: (212) 570-3000
FEATURED NEWS
- New York Blood Center Enterprises To Partner In Governor Hochul's Nation-Leading Cell And Gene Therapy Innovation Hub: New York Biogenesis Park
- NYBC Enterprises Acquires Commercial-Scale CGT Facilities